Ricky Alvarez

Jun 25, 2024 | highsnobiety.com | Ricky Alvarez |Sebastian Jean |Kyle Rice

Summer of Sexy: This summer, Highsnobiety explores all the ways personal style transcends what we wear. This special series delves into critical discussions and stories that highlight the body as a site of expression and exploration – social, sexual, and psychological.

Jun 21, 2023 | blogsite.healtheconomics.com | Ricky Alvarez

In this interview with Chad Rose, General Manager of hēRo3, he explains how biopharma is incorporating critical HEOR insights into decision-making for early pipeline assets. Why is there a need to revolutionize the way HEOR insights are used in the decision-making process? Now more than ever, there is a heightened importance for companies to ensure that bets made on new pipeline assets are both thoughtful and strategic.

May 9, 2023 | blogsite.healtheconomics.com | Ricky Alvarez

Precision medicine and value-based care are buzzwords used over the last two decades. At inception, these principles were seen as two opposing forces in the fight against cancer. Now, industry leaders view precision medicine and value-based care as two sides of the same coin. Data demonstrating the impact of value-based, precision medicine in oncology has started to emerge.

Mar 9, 2023 | blogsite.healtheconomics.com | Ricky Alvarez

The current healthcare environment reshapes the three key factors in market access – value, evidence, and commercial positioning of new treatments. Greater emphasis on patient centricity meets budget cuts. Leading to a sharper focus on demonstrating patient benefit value specific to the treatment situation. At the same time, the focus of new treatments is also being reshaped. To be more personalized in development and delivery.